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T cell immunity is characterized by striking tissue specialization.Tissue-specificity imprinting
starts during priming by tissue-derived migratory dendritic cells in the non-random, spe-
cialized micro-anatomical area of the draining lymph node and is influenced by constitutive
and induced cues from local environment. Besides tissue-specific effectors, memory cells
also exhibit a tissue-specificity. Long-lived tissue-resident memoryT cells likely play a con-
siderable role in preventing pathogen invasion. Understanding of the mechanisms of tissue
specialization ofT cells is of major importance for the design of optimal vaccination strate-
gies and therapeutic interventions in tissue/organ-specific inflammatory diseases. The
present review summarizes our current knowledge and hypothesis about tissue-specificity
imprinting and tissue residency of T cells.
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Generation of long-lasting systemic and tissue-specific memory T
cell responses is a fundamental characteristic of adaptive immu-
nity. According to the current paradigm, naturally pre-programed
and secondary lymphoid tissue (SLT)-oriented trafficking of recir-
culating naïve T cells switches dramatically to peripheral tissue-
oriented after antigen (Ag) exposure and priming in the T cell
zone environment of draining lymph node (DLN) (1). The role
of peripheral tissue-derived migratory dendritic cells (DCs) in
the imprinting of tissue-specific information is now well doc-
umented (2–5). Thus, DLNs can be considered as the body’s
“central processing units” incorporating tissue-specific informa-
tion into generated adaptive T cell responses. This response is
generated from two recirculating precursors characterized by con-
stitutive LN-tropism: naive and central memory (TCM) T cells.
Indeed, both populations share high expression of the LN-homing
molecules (CCR7 and CD62L) and recirculation marker S1P1
and generate tissue-specific short-lived effector cells (SLECs), the
major pool of terminally differentiated T cells highly active in
pathogen clearance. Although the role of CD8α+ resident DCs in
generation of tissue-specific SLECs in some types of infections
has been documented (6), peripheral tissue-derived migratory
DCs (CD207+CD103+ and CD11b+CD207−CD103− dermal
DCs and CD207+CD103− Langerhans cells, LCs) likely represent
major players involved in processing and transfer of skin-specific
information during priming and cross-priming processes (6, 7).
Recent multiparameter 3D imaging approach revealed striking
differences in migratory DCs-subset distribution within discrete
micro-anatomical compartments of skin DLN with preferen-
tial localization of CD11b+ dermal DCs within interfollicular
and outer paracortex area close to B cell zone and preferential
positioning of dermal CD207+CD103+ DCs and LCs within
deeper T cell zone (8). This non-random spatial segregation and
positioning of tissue-derived DCs subpopulations in DLN mir-
rors controlled trafficking and positioning of naive and TCM cell
subsets following priming and during recall T cell response, respec-
tively. In contrast to steady state where naive CD8+ T cells localize
mostly in the deep T cell area, recent observations point to the
crucial role of subfollicular region previously known as corti-
cal ridge and interfollicular area (IFA) as preferential sites of
both, positioning following CD8+ T cell priming and constitu-
tive prepositioning of CD8+ TCM cells (9, 10). Notably, in both
cases, tissue-specific SLECs are generated, which suggest a strik-
ing spatial overlap between local DLN functional microdomain
involved in generation of SLECs progeny regardless of the type
of adaptive immune response (primary or secondary). CXCL9-
CXCR3 receptor chemotactic axis has been identified to be a key
mechanism regulating repositioning of TCM to cortical ridge zone
and IFA and CXCR3 has been proposed to be a factor involved in
early programing of CD8+ T cells differentiation into SLECs since
CXCR3−/− CD8+ T cells preferentially differentiate into memory
precursor cells (MPECs) (9, 11, 12). Importantly, CXCR3 is a func-
tional marker shared by recently activated naïve T cells, SLECs, and
different subsets of memory T cells including the recently identi-
fied memory stem cell subset (TSCM) (13). Whether re-stimulation
of TSCM cells also takes place in the cortical ridge zone and IFA
remains to be established.
Tissue-specific imprinting during T cell priming and subse-
quent T cell differentiation into tissue-specific SLECs is thought
to involve induction of a set of surface homing molecules which
combinatorial usage generates lymphocyte’s tissue-specific zip
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code. Only a few molecular mechanisms involved in the periph-
eral tissue tropism of SLECs have so far been identified. Small-
intestine tropism of SLECs is imprinted by gut-associated DCs in
an all-trans retinoic acid (RA)-dependent manner. This involves
induction of a small intestine-specific zip code consisting of strong
integrin α4β7 and chemokine receptor CCR9 expression (4, 14).
Likewise, skin-derived DCs induce chemokine receptor CCR10
expression on T cells in a 1,25(OH)2D3-dependent manner and
thereby program generated SLECs to home to the skin (15). The
skin-specific zip code is characterized by concomitant and sequen-
tial usage of E-/P-selectin ligands (CLA), CCR4, CCR10, CCR8,
CCR6, αMβ2 (CD11b/CD18), and α4β1 (CD49d/CD29), among
other homing molecules (16). De novo expression of E-selectin lig-
ands on skin-tropic T cells requires activation-induced expression
of the α(1,3)fucosyltransferases FucT-IV and FucT-VII glycosyla-
tion enzymes (17, 18). Of note, expression of skin-tropic molecules
on lymphocytes is inhibited by RA, while 1,25(OH)2D3 negatively
regulates RA-controlled expression of α4β7 and CCR9 (14). The
molecular mechanisms that control homing of effector T cells
to other tissues remain largely unknown except of the recently
proposed role of CLEVER-1/stabilin-1 and VAP-1 in liver-specific
recruitment of Foxp3+ Tregs (19).
The lymphocyte tissue-specific zip codes in turn recognize yet
poorly defined vascular zip codes, a combinatorial set of endothe-
lial counter receptors for lymphocyte’s zip codes expressed by
post-capillary venules. Importantly, both types of zip code may
modify through induction of new surface markers and down
regulation of others, thus adapting cell trafficking to the type
of immune response and to dynamically changing inflammatory
conditions. The last notion is indeed supported by substantial
heterogeneity and dynamics of microvascular endothelial pheno-
type described within the same tissue compartment in response
to inflammatory stimuli (20). Phenotypic and functional mod-
ifications of local post-capillary endothelial cells (ECs) induced
by pro-inflammatory cytokines and inflammation-related fac-
tors, likely includes: (i) rearranged expression of adhesion mol-
ecules, glycosaminoglycan (GAGs) structures, and specific gly-
cosylation patterns of the endothelial cell surface-associated
molecules, (ii) active transport, transcytosis, and presentation
of inflammatory chemokines induced at sites of inflamma-
tion, at the abluminal surface of endothelial cells, (iii) synthesis
of lymphocyte-activating cytokines including chemokines (21–
23). Thus, although organ/tissue-specificity seems to be pre-
determined in the context of DLNs, precise tissue-specific posi-
tioning of SLECs seems to be characterized by sequential modifi-
cations of the expressed zip codes which are dynamically adjusted
according to the given step of cell trafficking process and local
inflammatory and metabolic cues.
Despite clear evidence for the imprinting of a specific hom-
ing pattern during T cell priming, this elegant model likely has
certain limitations, as several experimental studies of infectious
diseases have shown wider recirculation pattern and substantial
promiscuity in the trafficking programing, as well as a surpris-
ingly flexible tissue distribution of in vivo-induced SLECs (24–
26). However, large or biased homing patterns observed in some
models could be due to several immune and pathogen-related fac-
tors: (i) in vivo model used, (ii) artifacts related to high number
transfer of Ag-specific transgenic T cells (iii) low level of induc-
tion of broad-spectrum homing molecules such as mucosal T
cells-associated marker α4β7 integrin or inflammation-related
molecules (iv) immunization route (v) priming such as Ag load,
priming threshold, adjuvants and costimulation, polarization, or
regulatory signals, and (vi) target tissue-analyzed (more promiscu-
ous, mucosa-associated, and more restricted skin-specific homing
pattern), among others (24–29).
While the mechanisms controlling homing pattern of SLECs
has been extensively investigated, less attention has been paid to
the mechanisms that control the trafficking and tissue positioning
of long-lived memory T cell subsets, namely peripheral tissue-
resident memory (TRM) T cells. The simultaneous presence of
memory T cells with different anatomical distributions (systemic
and tissue/organ-specific) is likely to reflect the role of compart-
mentalization in the global strategy used by the immune system to
ensure optimal surveillance and protection (Figure 1). In this sce-
nario, similarly to SLECs, TEM cells do not express the LN-homing
molecules CD62L and CCR7, and thus traffic preferentially to
inflammatory sites of Ag encounter. However, a subset of TEM cells
likely can egress from peripheral inflammatory sites to local DLN
via afferent lymph, following transient expression of CCR7, and
then to the bloodstream and spleen (30–32). The proportion of
cells expressing CD62L within the circulating memory T cell pop-
ulation increases with increasing time after immunization. This
could be related to the higher survival and homeostatic prolifera-
tion of TCM relative to TEM (29). TCM cells continually re-circulate
between peripheral blood and SLT and account for the bulk of
long-lasting systemic immune memory and are the most impor-
tant precursors of tissue-specific TEM pool during recall response.
However, they are only moderately capable of homing to sites
of inflammation, and their ability to control localized infections
within peripheral tissues is thus very limited (33–36).
Tissue-resident memory cells in contrast are non-recirculating
long-lived pathogen-specific resident memory T cells perma-
nently associated with body surfaces (skin, intestine, lung, vaginal
mucosa) and with organs such as the brain, kidney, and pan-
creas, thus providing global organ/area-targeted protection (34,
37, 38). Skin TRM cells have potent effector capacities and appear
be superior to recirculating TCM cells at providing rapid long-
term protection against cutaneous re-infection (34). Several data
indicate that local environmental cues are required for TRM cell
maintenance within epithelia, as described for LC (38–41). Accord-
ing to this scenario, locally produced TGFβ could instruct specific
precursors within the TEM pool to follow a TRM fate. Some TRM
populations have been described to constitutively express CD8αα
homodimer (42). A possible hypothesis is that TRM precursors
require CD8αα and the interaction with its high affinity ligand(s)
such as thymic leukemia antigen (TL) for their differentiation and
survival, as described for intestinal intraepithelial lymphocytes
(IELs) (43).
Currently, there are no data supporting the hypothesis that
the TRM pool results from seeding by blood-borne TCM-derived
progeny. In contrast, it has been shown that TEM generated follow-
ing skin infection accumulate as TRM in a organ-specific manner
both, at site of infection and at distant sites (34). This suggests
that the TEM stage is the link between migratory DCS that harbor
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FIGURE 1 |Tissue-specific imprinting, trafficking, and tissue residency
of effector and memory CD8T cells. In this model, tissue-derived
migratory DC imprints tissue-specific homing pattern (symbolized by the
green arrows) in naive T cell during priming in the context of the deep T cell
zone of the draining lymph node. Primed T cells including SLECs and
MPECs relocalize into perifollicular T cell area. While SLECs migrate into
tissues through the blood, MPECs complete their differentiation into
memory subsets. Recirculating (TN, TCM, TSCM), transient (SLECs, TEM), and
long-term (TRM) non-recirculating CD8 T cell pools are shown. Unusual
trafficking pattern of CD4+ TRCM is also shown. CD4 helping signals for CD8
memory generation and possibly for TRM maintenance are also shown. TN,
naive CD8 T cell; SLEC, short-lived effector T Cell; MPEC, memory
precursor CD8 T cell; TSCM, stem cell memory CD8 T cell; TCM, central
memory CD8 T cell; TEM, effector memory CD8 T cell; TRM, resident
memory CD8 T cell; TRCM, recirculating memory CD4 T cell; HEV, high
endothelial venules.
tissue-specific information and TRM cells. This implies that the
tissue-specific information is conserved and transmitted along
this TEM–TRM differentiation pathway. However, TRM cells differ
markedly from blood TEM pool and the exact relations between
TEM and TRM is yet to be determined, especially whether TRM may
be viewed only as a resident form of blood-derived TEM (38, 44–
46). Commonly observed signature of the barrier tissue-associated
TRM cell population include strong expression of CD103, E-/P-
selectin ligands, CD44, CD69 (a negative regulator of recirculation
marker S1P1) (47), and CD49a/VLA-1. This phenotype is partially
shared with other E-cadherin-dependent epithelia-resident cells
such as dendritic epidermal γδ T cells (DETC) and IELs (35, 48).
High level of CD103 expression likely represents a key marker of
permanent barrier tissue residency of different types of TRM sub-
sets (42, 49). The phenotype of TRM cells is probably much more
heterogeneous, and future studies will likely identify new mole-
cules involved in TRM cell positioning and maintenance within
barrier as well as non-barrier peripheral tissues. Several obser-
vations suggest that TRM cells can persist long-term without any
external input (33, 44, 45, 49), therefore providing prolonged pro-
tection against pathogens. However, the observations of numerous
cases of progressive multifocal leukoencephalopathy (a devastat-
ing demyelinating disease due to JC virus reactivation in the brain)
in multiple sclerosis patients treated with natalizumab (50), a
therapeutic monoclonal antibody directed against the cell adhe-
sion moleculeα4-integrin that blocks T cell trafficking through the
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blood brain barrier, raises question about the long-term mainte-
nance of efficient brain-resident T cell memory without cell input
from peripheral blood.
A point of interest is the recent demonstration in the skin
of recirculating memory (TRCM) CD4 T cells which phenotypi-
cally differ from TEM, as they are CCR7pos, CD62Lint, CD103±
in addition to the expression of the peripheral homing receptor
E-selectin ligand (51). This unusual migration pattern is partially
shared by Foxp3+ Tregs that migrate from skin to draining LNs
via afferent lymphatics (52). Following activation, TRCM expressed
CD40L and produced IL-2 (51). Numerous reports have shown
the requirement of helping signals from CD4 T cell subsets for
the generation, maintenance, and reactivation of efficient sys-
temic CD8 memory (53–57). Whether help from CD4 TRCM
is required for the maintenance of CD8 TRM is a point that
deserves further investigations. Such a requirement of help from
recirculating CD4 T cells may provide an explanation for the dele-
terious role of natalizumab or efalizumab (another therapeutic
monoclonal antibody that targets the member of the integrin
family CD11a) (50) on brain-resident CD8 memory, despite the
intrinsic long-term survival of CD8 TRM cells. Another question
of interest is whether there is a CD8 counterpart of CD4 TRCM
cells. Figure 1 summarizes key points of our current understand-
ing of trafficking and tissue residency of effector and memory T
cell subsets.
We are still at the early beginning of the story and many ques-
tions remain unanswered about the mechanisms of tissue-specific
imprinting of effector and memory T cells and the maintenance of
resident T cell memory as well as the lineage relationships between
TRM and blood memory T cells. Unraveling those mechanisms
is of major importance for the design of new vaccination strate-
gies capable of inducing strong cell-mediated organ/tissue-specific
immunity and protection. Molecules involved in tissue/organ-
specific positioning of memory T cells might also represent inter-
esting therapeutic targets for a variety of tissue/organ-specific
inflammatory diseases.
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